We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cisplatin + RT for Triple Negative Breast Cancer

This study is currently recruiting participants.
Verified July 2017 by Jennifer Bellon, Dana-Farber Cancer Institute
Sponsor:
ClinicalTrials.gov Identifier:
NCT01674842
First Posted: August 29, 2012
Last Update Posted: July 26, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Jennifer Bellon, Dana-Farber Cancer Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2023
  Estimated Primary Completion Date: October 2018 (Final data collection date for primary outcome measure)